Cargando…

c-Met specific CAR-T cells as a targeted therapy for non-small cell lung cancer cell A549

Non-small cell lung cancer (NSCLC) is considered to be one of the most prevalent and fatal malignancies, with a poor survival rate. Chimeric antigen receptor T cell (CAR-T) cell therapy is one of the most exciting directions in the field of Cellular immunotherapy. Therefore, CAR-T cells that target...

Descripción completa

Detalles Bibliográficos
Autores principales:	Min, Jingting, Long, Chirong, Zhang, Lu, Duan, Jiakang, Fan, Honglian, Chu, Fei, Li, Zhenghong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161852/ https://www.ncbi.nlm.nih.gov/pubmed/35378051 http://dx.doi.org/10.1080/21655979.2022.2058149

Ejemplares similares

Tyrosine kinase signaling-independent MET-targeting with CAR-T cells
por: Qin, Anna, et al.
Publicado: (2023)

MET and Small-Cell Lung Cancer
por: Gelsomino, Francesco, et al.
Publicado: (2014)

Meeting an un-MET need: Targeting MET in non-small cell lung cancer
por: Michaels, Elena, et al.
Publicado: (2022)

Effect of DNA methylation inhibitor on RASSF1A genes expression in non-small cell lung cancer cell line A549 and A549DDP
por: Mengxi, Duan, et al.
Publicado: (2013)

Acquired Resistance of MET-Amplified Non-small Cell Lung Cancer Cells to the MET Inhibitor Capmatinib
por: Kim, Seulki, et al.
Publicado: (2019)

MET Oncogene in Non-Small Cell Lung Cancer: Mechanism of MET Dysregulation and Agents Targeting the HGF/c-Met Axis
por: Liang, Hongge, et al.
Publicado: (2020)

HGF/c-Met/β1-integrin signalling axis induces tunneling nanotubes in A549 lung adenocarcinoma cells
por: Awanis, Griselda, et al.
Publicado: (2023)

MicroRNA-7 Inhibits the Growth of Human Non-Small Cell Lung Cancer A549 Cells through Targeting BCL-2
por: Xiong, Shudao, et al.
Publicado: (2011)

Advances in CAR T Cell Therapy for Non-Small Cell Lung Cancer
por: Ma, Hong Yun, et al.
Publicado: (2023)

MET Inhibitor Capmatinib Radiosensitizes MET Exon 14-Mutated and MET-Amplified Non-Small Cell Lung Cancer
por: Ramesh, Shrey, et al.
Publicado: (2023)

Antitumor activity of EGFR-specific CAR T cells against non-small-cell lung cancer cells in vitro and in mice
por: Li, He, et al.
Publicado: (2018)

CRTC2 promotes non‐small cell lung cancer A549 migration and invasion in vitro
por: Shi, Shaoqing, et al.
Publicado: (2017)

Efficacy of CAR-T immunotherapy in MET overexpressing tumors not eligible for anti-MET targeted therapy
por: Chiriaco, Cristina, et al.
Publicado: (2022)

Radiosensitization effects of curcumin plus cisplatin on non-small cell lung cancer A549 cells
por: Cai, Yong, et al.
Publicado: (2019)

Targeting PD-L1 in non-small cell lung cancer using CAR T cells
por: Liu, Ming, et al.
Publicado: (2020)

LunX-CAR T Cells as a Targeted Therapy for Non-Small Cell Lung Cancer
por: Hu, Ziming, et al.
Publicado: (2020)

MicroRNA-373 Inhibits Cell Proliferation and Invasion via Targeting BRF2 in Human Non-small Cell Lung Cancer A549 Cell Line
por: Wang, Lei, et al.
Publicado: (2018)

Small interfering RNA targeting S100A4 sensitizes non-small-cell lung cancer cells (A549) to radiation treatment
por: Qi, Ruixue, et al.
Publicado: (2016)

Strain-specific behavior of Mycobacterium tuberculosis in A549 lung cancer cell line
por: Hadifar, Shima, et al.
Publicado: (2021)

Impact of MET inhibition on small‐cell lung cancer cells showing aberrant activation of the hepatocyte growth factor/MET pathway
por: Taniguchi, Hirokazu, et al.
Publicado: (2017)

Targeting the MET-Signaling Pathway in Non-Small–Cell Lung Cancer: Evidence to Date
por: Bylicki, Olivier, et al.
Publicado: (2020)

Radiosensitizing effects of Cyclocarya paliurus polysaccharide on hypoxic A549 and H520 human non-small cell lung carcinoma cells
por: Zhang, Fengmin, et al.
Publicado: (2019)

Xanthohumol induces apoptosis and S phase cell cycle arrest in A549 non-small cell lung cancer cells
por: Yong, Wai Kuan, et al.
Publicado: (2015)

Staurosporine Induces the Generation of Polyploid Giant Cancer Cells in Non-Small-Cell Lung Carcinoma A549 Cells
por: Glassmann, Alexander, et al.
Publicado: (2018)

MET Inhibitors in Small Cell Lung Cancer: From the Bench to the Bedside
por: Hardy-Werbin, Max, et al.
Publicado: (2019)

Pressure increases PD-L1 expression in A549 lung adenocarcinoma cells and causes resistance to anti-ROR1 CAR T cell-mediated cytotoxicity
por: Ou, Zhenglin, et al.
Publicado: (2022)

MiR-1244 sensitizes the resistance of non-small cell lung cancer A549 cell to cisplatin
por: Li, Weili, et al.
Publicado: (2016)

Effect of hyperoside on the apoptosis of A549 human non-small cell lung cancer cells and the underlying mechanism
por: Yang, Yu, et al.
Publicado: (2017)

Piceatannol Enhances the Antitumor Efficacy of Gemcitabine in Human A549 Non-Small Cell Lung Cancer Cells
por: Xu, Bin, et al.
Publicado: (2015)

MET Inhibitor is Expected to Overcome MET Amplification-Induced Immunotherapy Resistance in Non-Small Cell Lung Cancer
por: Ruan, Ji
Publicado: (2021)

Matrine induces cell cycle arrest and apoptosis with recovery of the expression of miR-126 in the A549 non-small cell lung cancer cell line
por: An, Qi, et al.
Publicado: (2016)

Non-Small Cell Lung Cancer Targeted Therapy: Drugs and Mechanisms of Drug Resistance
por: Wu, Jiajia, et al.
Publicado: (2022)

Rhizoma Paridis Saponins Induces Cell Cycle Arrest and Apoptosis in Non-Small Cell Lung Carcinoma A549 Cells
por: Zhang, Jue, et al.
Publicado: (2015)

Correlation among genetic variations of c-MET in Chinese patients with non-small cell lung cancer
por: Duan, Jianchun, et al.
Publicado: (2017)

Targeting MET in Non-Small Cell Lung Cancer (NSCLC): A New Old Story?
por: Spagnolo, Calogera Claudia, et al.
Publicado: (2023)

PD-L1 and c-MET expression and survival in patients with small cell lung cancer
por: Miao, Lulu, et al.
Publicado: (2017)

Interleukin-1β weakens paclitaxel sensitivity through regulating autophagy in the non-small cell lung cancer cell line A549
por: Lian, Juanwen, et al.
Publicado: (2021)

Anti-Proliferative and Apoptosis-Inducing Effect of Theabrownin against Non-small Cell Lung Adenocarcinoma A549 Cells
por: Wu, Feifei, et al.
Publicado: (2016)

Evaluation of Anti-Metastatic Potential of the Combination of Fisetin with Paclitaxel on A549 Non-Small Cell Lung Cancer Cells
por: Klimaszewska-Wiśniewska, Anna, et al.
Publicado: (2018)

UNBS5162 inhibits the proliferation of human A549 non‐small‐cell lung cancer cells by promoting apoptosis
por: Liu, Cuicui, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9qnqkd03u6b0mlucd8m9itu1rv